Health and Fitness Health and Fitness
Mon, December 6, 2010
Fri, December 3, 2010
Thu, December 2, 2010
Wed, December 1, 2010
Tue, November 30, 2010
[ Tue, Nov 30th 2010 ] - Market Wire
2005 Certification
Mon, November 29, 2010
Thu, November 25, 2010
Wed, November 24, 2010
Tue, November 23, 2010
Mon, November 22, 2010
Sat, November 20, 2010
Fri, November 19, 2010
Thu, November 18, 2010
Wed, November 17, 2010
Tue, November 16, 2010
Mon, November 15, 2010
Sun, November 14, 2010
Fri, November 12, 2010
Thu, November 11, 2010
Wed, November 10, 2010
Tue, November 9, 2010

POZEN to Present at the 22nd Annual Piper Jaffray Healthcare Conference


//health-fitness.news-articles.net/content/2010/ .. -annual-piper-jaffray-healthcare-conference.html
Published in Health and Fitness on Friday, November 19th 2010 at 4:35 GMT by Market Wire   Print publication without navigation


CHAPEL HILL, N.C.--([ BUSINESS WIRE ])--POZEN Inc. (NASDAQ: POZN) announced today that John R. Plachetka, Pharm.D., the Companya™s Chairman, President and Chief Executive Officer, will present at the 22nd Annual Piper Jaffray Healthcare Conference on Tuesday, November 30, 2010 at 3:30 p.m. (EST), at the New York Palace Hotel in New York City. Dr. Plachetkaa™s discussion will be webcast and available for replay on POZENa™s home page at [ www.pozen.com ].

About POZEN

POZEN Inc. is a progressive pharmaceutical company that is transforming how the healthcare industry addresses unmet medical needs. By utilizing a unique in-source model and a focus on integrated therapies, POZEN has successfully developed and obtained FDA approval of two self-invented products in two years a" something almost no other small pharmaceutical company has done. Funded by these two milestone/royalty streams, POZEN is now creating a portfolio of cost-effective integrated aspirin therapies designed to enable the full power of aspirin by reducing its GI toxicity. The lead candidate, PA32540, is being investigated for the secondary prevention of cardiovascular disease and has entered Phase 3 clinical trials. POZEN is retaining commercial control of the pipeline assets and will launch creatively using a new sales force model and digital communications. The Company's common stock is traded on The NASDAQ Stock Market under the symbol "POZN". For more detailed company information, including copies of this and other press releases, please visit: [ www.pozen.com ].


Publication Contributing Sources